{"nct_id":"NCT03345836","title":"A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy","status":"COMPLETED","status_verified_date":"2022-07","start_date":"2017-11-29","start_date_type":"ACTUAL","primary_completion_date":"2021-08-11","primary_completion_date_type":"ACTUAL","completion_date":"2021-08-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}